News

Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns
Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with ...
GLP-1 Pill From Eli Lilly Leads to Weight Loss and May Be Available Next Year
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
India Today on MSN5d
Eli Lilly's oral pill shows similar results to popular weight-loss drugs
A new oral anti-diabetes pill, orforglipron, shows similar effectiveness to injectable GLP-1 drugs in a Phase 3 trial.
New diabetes drug may outperform Ozempic jab
The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...
heraldsun.com.au6d
New Eli Lilly diabetes, obesity pill may outperform Ozempic - Herald Sun
Eli Lilly research shows their new GLP-1 pill successfully lowered patient’s weight and blood sugars, with some patients responding so well their levels no longer met the threshold for diabetes.